Literature DB >> 12054930

Amino acid derived heterocycles: lewis acid catalyzed and radical cyclizations from peptide acetals.

Matthew H Todd1, Chudi Ndubaku, Paul A Bartlett.   

Abstract

Bicyclization of peptide acetals via nucleophilic attack of a phenyl group on an endocyclic acyliminium ion 4 was explored as a route to novel amino acid derived heterocycles and peptidomimetic scaffolds. In the presence of protic acid, bridged structures such as 6 are formed readily from phenylalanine derivatives, but the fused-ring analogues 5 could not be obtained in good yield. In contrast, radical cyclization of the bromophenyl dihydropyrazinone 7 provides an effective alternative for the synthesis of 5 (n = 0, 1, 2). Additional versatility in this process was demonstrated by efficient synthesis of a different fused ring system, represented by the antihelmintic praziquantel, 8.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054930     DOI: 10.1021/jo010990m

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  MCR synthesis of praziquantel derivatives.

Authors:  Haixia Liu; Samia William; Eberhardt Herdtweck; Sanaa Botros; Alexander Dömling
Journal:  Chem Biol Drug Des       Date:  2012-01-30       Impact factor: 2.817

2.  CYCLOADDITION REACTIONS OF AZIDE, FURAN, AND PYRROLE UNITS WITH BENZYNES GENERATED BY THE HEXADEHYDRO-DIELS-ALDER (HDDA) REACTION.

Authors:  Junhua Chen; Beeraiah Baire; Thomas R Hoye
Journal:  Heterocycles       Date:  2014-01-01       Impact factor: 0.831

3.  Brønsted acid-mediated cyclization-dehydrosulfonylation/reduction sequences: An easy access to pyrazinoisoquinolines and pyridopyrazines.

Authors:  Ramana Sreenivasa Rao; Chinnasamy Ramaraj Ramanathan
Journal:  Beilstein J Org Chem       Date:  2017-03-07       Impact factor: 2.883

4.  The outcome of the oxidations of unusual enediamide motifs is governed by the stabilities of the intermediate iminium ions.

Authors:  Muneer Ahamed; Bun Chan; Paul Jensen; Matthew H Todd
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.